Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 72%
filed 2026-06-15
Item 8.01
The Board authorized a new 15,000,000-share repurchase program on June 15, 2026, replacing the prior 2024 program. While share repurchase authorizations are routine capital allocation decisions, this disclosure is material to investors as it signals management's confidence in valuation and affects future earnings per share and capital deployment strategy. However, it does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or covenant breach), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of WW International's 2026 annual shareholder meeting held on June 12, 2026. The filing presents voting tallies for three proposals: (1) election of six directors, (2) ratification of PricewaterhouseCoopers LLP as independent auditor, and (3) advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material shareholder vote result disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-15
Item 2.02
The filing discloses Gencor Industries' financial results for the second quarter of fiscal 2026 via a press release issued on June 12, 2026, attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly financial performance information.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
Stockholders approved five proposals at the Annual Meeting: election of directors Stefan Krause and Lily Mei, ratification of Frank, Rimerman + Co. LLP as independent auditor, advisory approval of named executive officer compensation, annual frequency for say-on-pay votes, and an amendment to the 2021 Equity Incentive Plan increasing authorized shares by 2,860,000 and raising aggregate ISOs to 10,000,000. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder vote results from Lyell Immunopharma's June 10, 2026 annual meeting, covering three proposals: election of Class II directors (Richard Klausner, Otis Brawley, William Rieflin), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents certified voting tallies including votes for/against, withholdings, abstentions, and broker non-votes for each matter, which is the hallmark of Item 5.07 disclosure and directly matches the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-15
Item 1.01
Fox Corporation entered into a definitive merger agreement with Roku, Inc. on June 14, 2026, whereby Fox will acquire Roku through a two-step merger structure for consideration consisting of 0.9693 shares of Fox Class A Common Stock and $96.00 in cash per share. This is a material acquisition transaction requiring disclosure under Item 1.01, with substantial merger consideration, regulatory conditions (HSR Act approval), stockholder votes, and termination fees of $866 million and $1.237 billion, indicating a significant change of control transaction material to both parties' investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder voting results from the Company's 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing reports results for two proposals: election of Class II directors (Craig Dixon and Adam Stewart) and ratification of Deloitte & Touche LLP as independent auditor. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-06-15
EX-99.1
The exhibit is a press release announcing a quarterly dividend declaration by TFI International's Board of Directors of US $0.47 per common share, payable July 15, 2026 to shareholders of record on June 30, 2026. This is a routine but material capital distribution to shareholders that would affect investor assessment of the company's capital allocation and shareholder returns.
View raw filing on EDGAR →
8-K
M&A activity
confidence 82%
filed 2026-06-15
Item 1.01
The Company entered into material definitive agreements for a debt restructuring transaction, including the issuance of new First Lien Notes (9.000%) and Second Lien Notes (9.750%) pursuant to indentures dated June 15, 2026, issued in exchange for existing notes. The transaction also includes amendments to existing note indentures and a Fourth Amendment to the Credit Agreement, with early results of the Exchange Offers and Consent Solicitations announced on June 10, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-15
Item 8.01
The Company announced an intended offering of $250 million in convertible senior notes due 2031 to qualified institutional buyers, with an additional $37.5 million option. Convertible notes are dilutive securities that create potential equity dilution upon conversion. While the filing also mentions a business separation, the primary 8-K disclosure centers on the convertible debt offering, which is a material capital-raising event typical of dilutive issuances.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-15
Item 8.01
This disclosure reports the Company's monthly Net Asset Value (NAV) per share as of May 31, 2026, calculated in accordance with board-approved valuation guidelines. The filing provides detailed breakdowns of NAV components (commercial mortgage loans, real estate owned, liabilities, etc.) and NAV per share across six share classes. While NAV disclosures are routine for non-traded REITs and investment companies, this particular filing is material to investors as it directly affects share valuation, redemption pricing, and investor assessment of the Company's asset base and financial position. The disclosure does not fit neatly into more specific event categories (not earnings, not M&A, not impairment, etc.), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder vote results from Pyxis Oncology's Annual Meeting of Stockholders held on June 15, 2026. The filing reports the final voting tallies for two proposals: (1) election of three Class II directors (Thomas Civik, Freda Lewis-Hall, and Michael A. Metzger) and (2) ratification of Ernst & Young LLP as independent auditor. The detailed vote counts (For, Against/Withheld, Abstain, and Broker Non-Votes) are provided for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-15
EX-99.1
The exhibit announces the results of Navigator Gas's 2026 Annual General Meeting of Shareholders held on June 15, 2026. It discloses that shareholders approved two proposals: (1) election of six directors (Dag von Appen, Dr. Heiko Fischer, Janette Marx, Dr. Anita Odedra, Peter Stokes, and Florian Weidinger) to serve until the 2027 Annual General Meeting, and (2) ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026. This is a direct disclosure of shareholder vote results, which is material to investors as it establishes the composition of the board and confirms the auditor for the fiscal year.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder vote results from BJ's Restaurants' Annual Meeting of Shareholders held on June 11, 2026, covering three matters: election of eight directors (all elected with substantial majorities), advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. The detailed vote tallies for each director and each proposal are the hallmark of Item 5.07 disclosure, and the outcomes are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-06-15
Item 1.01
The disclosure describes establishment of a formal compensation plan for non-employee directors, specifying annual cash compensation ($100,000) and equity grants (750 restricted shares). This is a compensatory arrangement for directors that would materially affect investor assessment of governance and executive costs. While filed under Item 1.01 (typically for M&A), the substance is director compensation plan adoption, which falls under exec_compensation.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-15
Item 5.02
Jonathan Baldwin, Executive Vice President of Government Solutions, is departing the Company effective July 9, 2026. The disclosure centers on the departure itself and associated severance benefits under his employment agreement. While severance terms are mentioned, the principal disclosed action is the executive's departure, making this an exec_departure event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-15
Item 7.01
The disclosure announces completion of an acquisition by Westlake Vinnolit GmbH & Co. KG (a wholly owned subsidiary) of a polyvinyl chloride and vinyl chloride monomer production site in Wilhelmshaven, Germany. This is a material acquisition activity that would affect investor assessment of the company's strategic positioning and asset base, even though disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 1.01 or 2.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
TerrAscend held its Annual Meeting of Security Holders on June 9, 2026, with shareholders voting on four proposals: election of five directors, ratification of auditor re-appointment, approval of stock option plan, and approval of share unit plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
Shareholders approved four proposals at the Annual Meeting: election of four directors (Laura Dempsey Brown, Cariappa Chenanda, Alexander Schuetz, and Ian Walsh), ratification of Grant Thornton LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment and restatement of the 2023 Equity Incentive Plan increasing the share pool by 1,000,000 shares. All proposals passed with substantial majorities.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-06-15
EX-99.1
Bank of Montreal announces redemption of $1 billion Series K Medium-Term Notes (NVCC Subordinated Indebtedness) on July 22, 2026. While technically a redemption (retirement) of existing debt rather than issuance of new debt, this represents a material modification of the registrant's direct financial obligations and capital structure. The redemption requires regulatory approval from the Office of the Superintendent of Financial Institutions and involves a significant subordinated debt instrument, making it material to investors assessing the bank's leverage and capital position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-15
Item 5.02
Elliott Rodgers was appointed Chief Operating Officer of Kohl's Corporation, effective September 9, 2026. While the disclosure includes detailed compensatory arrangements (salary of $900,000, signing incentive of $400,000, long-term incentive target of $2,500,000, and other benefits), the principal disclosed action is the appointment of a named executive to a C-suite officer role. This is material to investors as it signals a significant leadership change at a major retailer.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a clear disclosure of shareholder voting results from TechTarget's June 11, 2026 Annual Meeting of Stockholders under Item 5.07. The filing presents detailed vote tallies for three proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. All proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and management accountability.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-15
Item 1.01
PureCycle Technologies entered into material definitive agreements on June 10, 2026, including an underwriting agreement for $287.5 million in convertible senior notes due 2032, an underwriting agreement for 19.85 million shares of common stock raising approximately $154.2 million in net proceeds, and repurchase agreements to retire approximately $216 million of existing Green Convertible Notes for approximately $246.3 million in cash, representing a significant capital restructuring and refinancing of the company's capital structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-15
Item 1.01
Teleflex issued $500 million in senior notes on June 15, 2026, pursuant to a definitive indenture agreement. This material debt issuance creates a direct financial obligation and represents a significant capital structure transaction.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-15
Item 8.01
The filing discloses drilling and exploration results at the Shiloh Project via press release under Item 8.01 (Other Events). For a rare earths exploration company, material drilling results and project updates are typically significant to investors assessing resource potential and development progress. However, without access to the actual press release content (Exhibit 99.1), the specific materiality cannot be definitively assessed—the event could range from routine operational updates to discovery-level results. Classified as other_material given the exploration-stage context and lack of a more specific taxonomy match.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of the 2026 annual meeting of stockholders held on June 12, 2026. The filing details three matters voted upon: (1) election of Class III director Michael Kauffman, M.D., Ph.D. (96.04% approval), (2) advisory approval of named executive officer compensation (98.0% approval), and (3) ratification of PricewaterhouseCoopers LLP as independent auditor (99.5% approval). All three are routine shareholder votes with strong approval margins, making this a material disclosure of governance outcomes.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-15
Item 8.01
The filing discloses a Board decision to pursue dissolution and complete liquidation of ARI, requiring stockholder approval and filing of a preliminary proxy statement. While this is a transformative event materially affecting the company's future, it does not fit neatly into the specific taxonomy categories (not a bankruptcy filing, since it is a planned orderly liquidation; not M&A activity, since no specific transaction is announced; not going_concern, which typically addresses doubt about continuation). The dividend announcement is secondary to the dissolution disclosure.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-06-15
The Company exchanged 1,330 Series A convertible preferred shares held by an investor for 1,330 newly created Series B convertible preferred shares with substantially identical terms. While technically an exchange rather than a new issuance, the creation of new Series B Preferred Shares with conversion rights represents a dilutive capital structure modification. The transaction involves convertible securities that could dilute common equity upon conversion, and the Certificate of Designations was adopted to establish the new preferred class, making this a material capital event affecting shareholder interests.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-06-15
EX-99.1
The press release announces that Sinovac "regained compliance with Nasdaq Global Market's listing requirements" after receiving a notification letter dated June 10, 2026, from the Nasdaq Hearing Advisor. This disclosure directly addresses a prior delisting risk or non-compliance status. The company remains under "Mandatory Panel Monitor" until May 20, 2027, indicating it was previously out of compliance with Listing Rule 5250(c)(1). This is a material event affecting the registrant's continued listing status on Nasdaq.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-15
Item 8.01
The filing discloses a merger transaction (the "Merger") contemplated by a Merger Agreement, with USAR filing Amendment No. 1 to its preliminary proxy statement on June 15, 2026, and updated pro forma financial statements reflecting the merger's effects. The disclosure centers on the material acquisition activity—specifically the merger with Serra Verde Group (SVRE)—which requires stockholder approval and is a change-of-control event material to investors.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-06-15
EX-99.1
This is a press release dated June 10, 2026, disclosing Scinai's first-quarter 2026 financial results (three months ended March 31, 2026), including revenues, operating loss, net income, and balance-sheet metrics. The exhibit includes condensed consolidated financial statements (balance sheet, income statement, cash flows, and changes in shareholders' equity) and a corporate update. While the release also discusses the Recipharm Israel acquisition and strategic initiatives, the primary disclosure is the quarterly financial results, which is characteristic of an earnings_release. The acquisition is presented as a completed transaction within the results narrative rather than as a discrete M&A event announcement.
View raw filing on EDGAR →
6-K
Operational Other
confidence 82%
filed 2026-06-15
EX-99.1
Ascentage Pharma disclosed seventeen clinical updates from its core assets—olverembatinib (HQP1351) and lisaftoclax (APG-2575)—presented at the EHA2026 Congress, including efficacy and safety data from multiple Phase II and Phase III studies across hematologic malignancies. Key highlights include Phase III POLARIS-1 data showing 94.4% CR/CRi rate in Ph+ ALL and Phase II data supporting olverembatinib as second-line therapy in CML, representing material progress toward regulatory approval and commercial potential.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-15
Item 7.01
The disclosure updates investors on the Company's carried interest position in special purpose vehicles holding shares of Space Exploration Technologies Corp. This represents a material update to shareholders regarding a significant asset holding (carried interest in SpaceX), which would affect a reasonable investor's assessment of the registrant's portfolio and financial position. However, without seeing the full press release content, the precise nature of the update (valuation change, structural modification, or other development) cannot be definitively categorized into a more specific event type, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-15
The filing discloses Item 5.07 results from Rumble Inc.'s 2026 Annual Meeting of Stockholders held on June 11, 2026. The company reports voting results for two proposals: (1) election of six directors to one-year terms with vote tallies for each nominee (e.g., Chris Pavlovski received 1,153,778,948 votes for), and (2) ratification of Baker Tilly US, LLP as independent auditor with 1,284,679,467 votes for. These are standard shareholder meeting outcomes that are material to investors' understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 97%
filed 2026-06-15
Item 3.01
Functional Brands Inc. received a written Staff Delisting Determination from Nasdaq on June 9, 2026, pursuant to the Low Priced Stocks Rule, triggered by the Company's closing bid price of $0.10 or less for ten consecutive trading days. Trading suspension is scheduled for June 16, 2026, with a Form 25-NSE to be filed to remove the Company's securities from listing, though the Company intends to appeal before a Panel and demonstrate a plan to regain compliance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-15
Item 1.01
Autodesk entered into two credit agreements on June 15, 2026, to finance its merger transaction with MaintainX Inc.: a Revolver Amendment increasing the revolving credit facility from $1.5 billion to $2 billion and a new $1.0 billion delayed draw term loan facility. These financing arrangements are material components directly supporting the merger's consummation.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-15
The filing discloses the appointment of Mr. Wong Tai Kok as an Independent Director and Chair of the Nomination Committee effective June 12, 2026, approved by the Board, Nomination Committee, and Compensation Committee. While the filing also mentions Mr. Henliyanto Ngadini's resignation, the principal disclosed action is the appointment of a new director to a leadership role (Chair of Nomination Committee), making exec_appointment the primary classification. The appointment includes compensation terms (US$10,000 annually) and biographical information, consistent with standard director appointment disclosures.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-15
The filing discloses unregistered sales of 6,070,948 shares of common stock by certain stockholders, with 3,019,066 shares acquired in connection with the acquisition of Omnisys Ltd. and 3,051,882 shares acquired in connection with the acquisition of Indo Earth Moving Ltd. Item 3.02 explicitly references unregistered sales of equity securities exempt under Regulation S, and the prospectus supplement covers resale of these shares. This represents a dilutive issuance material to investors assessing ownership and capital structure.
View raw filing on EDGAR →
6-K
Other material
confidence 75%
filed 2026-06-15
The Company withdrew its Form F-1 registration statement (File No. 333-295510) effective June 15, 2026, and determined not to pursue the related public offering. This is a material capital-raising event that failed to proceed — the withdrawal of a pending IPO registration statement would affect a reasonable investor's assessment of the registrant's financing plans and strategic direction. While not a standard 8-K category, this is clearly a material financial/strategic event that does not fit neatly into the taxonomy (not a debt issuance, dilutive issuance, or M&A activity, but rather a failed equity offering).
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-15
The 6-K discloses the results of an Extraordinary General Meeting held on June 12, 2026, where shareholders voted on five material proposals: (1) increase of Class B voting rights from 20 to 100 votes per share, (2) increase of authorized share capital, (3) reduction of par value, (4) adoption of amended charter, and (5) approval of up to five share consolidations at ratios up to 1:1500. All proposals were approved with overwhelming majorities (178.5M+ votes in favor). These charter amendments and voting-rights changes are material governance events affecting the capital structure and shareholder rights.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-15
EX-99.1
This press release announces a key human performance and characterization study for NASARIX™ (PL-14), Polyrizon's lead investigational product, conducted in collaboration with a leading European university medical center. The study is designed to evaluate nasal residence time—a critical performance parameter supporting the company's FDA regulatory pathway and development strategy. For a development-stage biotech company, advancement of a lead product through human studies and regulatory milestones is material to investor assessment of progress and value.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-15
Item 8.01
The filing discloses an extension of the initial business combination deadline for a SPAC (blank-check company) from June 17, 2026 to July 16, 2026, contingent on the sponsor depositing $10,000 into the trust account. While this is a routine SPAC administrative action, the extension of the termination date is material to shareholders as it directly affects the timeline for completing the business combination and the potential return of capital if no combination is consummated. This does not fit neatly into the more specific event categories but is clearly material to investors in a SPAC.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-15
Item 2.02
The filing discloses a press release announcing financial results for fiscal year 2026 fourth quarter and full year ended March 31, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-15
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Protara Therapeutics' Annual Meeting of Stockholders held on June 12, 2026. The filing presents voting results for seven proposals including director elections, auditor ratification, executive compensation approval, equity plan amendment, and charter amendments. Shareholder vote results are material to investors as they reflect stockholder approval of governance and compensation matters.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 93%
filed 2026-06-15
Item 1.01
Zeo Energy Corp. entered into a Note Purchase Agreement with White Lion Capital on June 9, 2026, to issue convertible notes with aggregate funded potential of $7.5 million. The convertible notes are convertible into Class A Common Stock at a conversion price subject to ownership limitations and a 19.99% Conversion Cap, with the Company obligated to seek stockholder approval for issuances exceeding the cap.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-06-15
The filing's primary disclosure is Item 5.07, which reports the results of a special stockholder meeting held on June 12, 2026. The meeting voted on four proposals: (1) approval of a corporate name change from "urban-gro, Inc." to "Flash Sports & Media Holdings, Inc." (787,843 votes for); (2) approval of share issuance upon conversion of Series B Convertible Preferred Stock exceeding 19.99% of outstanding shares (439,372 votes for); (3) approval of share issuance to Hudson Global Ventures and Agile Hudson Partners exceeding 19.99% of outstanding shares (427,276 votes for); and (4) adjournment authority (677,977 votes for). All proposals passed. The name change and dilutive share issuances are material to investors' assessment of the company's capital structure and identity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-15
Item 1.01
Quantum Cyber N.V. entered into a material intellectual property license agreement with Project LightShift on June 11, 2026, granting rights to quantum antenna technology for defense and national security applications. The transaction involves $1 million in cash payments plus $5 million in restricted ordinary shares issued over eight quarters, with a contingent exclusive right of first negotiation for a joint venture or royalty arrangement upon prototype delivery.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-15
Item 8.01
Churchill Capital Corp XII announced the commencement of separate trading of Class A Ordinary Shares and Warrants from their Units, effective June 17, 2026. This is a material corporate action affecting the trading structure and liquidity of the company's securities, but does not fit neatly into the more specific event categories (it is not M&A, an executive change, a restatement, or other defined event types). The disclosure affects how investors can trade the underlying securities and is therefore material to the total mix of information available.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-15
EX-99.1
This exhibit is a formal "Report of Voting Results" for Collective Mining's Annual and Special Meeting of Shareholders held on June 15, 2026, disclosing the outcomes of four shareholder votes: election of five directors (all carried with >99% support), appointment of BDO Canada LLP as auditor (carried with 99.998% support), adoption of a new omnibus equity incentive plan (carried with 91.236% support), and approval of unallocated awards under the existing stock option plan (carried with 91.236% support). This is a classic shareholder_vote_results disclosure required under National Instrument 51-102 Section 11.3.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-15
The filing discloses entry into a Share Purchase Agreement on June 12, 2026, whereby Future FinTech Group Inc. (through its subsidiary Future Commercial Group Limited) agreed to acquire a 20% equity interest in Xi'an Changshida Information Technology Co., Ltd. for approximately US$6.46 million in cash and stock consideration. This is a material acquisition transaction disclosed under Item 1.01 (Entry into a Material Definitive Agreement), with the company also disclosing an unregistered equity issuance of 493,062 shares under Item 3.02 as part of the purchase price.
View raw filing on EDGAR →